WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) claims that a safety trial for the weight-loss drug lorcaserin, sold by the brand name Belviq and Belviq XR, proved that taking the drug increases the risk of developing cancer. As a result of the FDA’s interpretation of the trial results, Eisai, the maker of Belviq, … [Read more...] about Weight Loss Drugs Belviq and Belviq XR Connected to Cancer and Force Recall

WASHINGTON, D.C. — Prescription drug manufacturer Eisai will pull its weight-loss drug Belviq from circulation after the U.S. Food and Drug Administration (FDA) found a link between taking Belviq and certain cancers. According to CNN, clinical trials showed that a large number of people who took Belviq to help with weight loss … [Read more...] about FDA Asks for Withdrawal of Belviq After Finding Cancer Link